While initial studies focused on serum, recent rigorous analyses of cerebrospinal fluid (CSF) have found that reduced CSF irisin levels are strongly associated with core AD biomarkers (Aβ pathology), global cognitive efficiency (MMSE), and deficits in specific cognitive domains like memory and executive function [19,20,21]. This evidence concerns the gene FNDC5 and Alzheimer disease.